% Encoding: UTF-8

@Article{handel07,
  author =      {Handel, Andreas and Longini, Jr, Ira M and Antia, Rustom},
  title =       {Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread.},
  journal =     {PLoS Comput Biol},
  year =        {2007},
  volume =      {3},
  number =      {12},
  pages =       {e240},
  month =       {Dec},
  abstract =    {Neuraminidase Inhibitors (NI) are currently the most effective drugs against influenza. Recent cases of NI resistance are a cause for concern. To assess the danger of NI resistance, a number of studies have reported the fraction of treated patients from which resistant strains could be isolated. Unfortunately, those results strongly depend on the details of the experimental protocol. Additionally, knowing the fraction of patients harboring resistance is not too useful by itself. Instead, we want to know how likely it is that an infected patient can generate a resistant infection in a secondary host, and how likely it is that the resistant strain subsequently spreads. While estimates for these parameters can often be obtained from epidemiological data, such data is lacking for NI resistance in influenza. Here, we use an approach that does not rely on epidemiological data. Instead, we combine data from influenza infections of human volunteers with a mathematical framework that allows estimation of the parameters that govern the initial generation and subsequent spread of resistance. We show how these parameters are influenced by changes in drug efficacy, timing of treatment, fitness of the resistant strain, and details of virus and immune system dynamics. Our study provides estimates for parameters that can be directly used in mathematical and computational models to study how NI usage might lead to the emergence and spread of resistance in the population. We find that the initial generation of resistant cases is most likely lower than the fraction of resistant cases reported. However, we also show that the results depend strongly on the details of the within-host dynamics of influenza infections, and most importantly, the role the immune system plays. Better knowledge of the quantitative dynamics of the immune response during influenza infections will be crucial to further improve the results.},
  doi =         {10.1371/journal.pcbi.0030240},
  institution = {Department of Biology, Emory University, Atlanta, Georgia, United States of America. ahandel@emory.edu},
  keywords =    {Antiviral Agents, therapeutic use; Computer Simulation; Disease Outbreaks, prevention /&/ control; Drug Resistance, Viral, immunology; Humans; Influenza A virus, physiology; Influenza, Human, drug therapy/epidemiology/immunology/transmission/virology; Models, Biological; Models, Immunological; Neuraminidase, antagonists /&/ inhibitors; Risk Assessment, methods; Risk Factors; Virus Replication, immunology},
  language =    {eng},
  medline-pst = {ppublish},
  pii =         {07-PLCB-RA-0281},
  pmc =         {PMC2134965},
  pmid =        {18069885},
  url =         {http://dx.doi.org/10.1371/journal.pcbi.0030240}
}

@Article{handel07a,
  author =      {Handel, Andreas and Longini, Jr, Ira M and Antia, Rustom},
  title =       {What is the best control strategy for multiple infectious disease outbreaks?},
  journal =     {Proc Biol Sci},
  year =        {2007},
  volume =      {274},
  number =      {1611},
  pages =       {833--837},
  month =       {Mar},
  abstract =    {Effective control of infectious disease outbreaks is an important public health goal. In a number of recent studies, it has been shown how different intervention measures like travel restrictions, school closures, treatment and prophylaxis might allow us to control outbreaks of diseases, such as SARS, pandemic influenza and others. In these studies, control of a single outbreak is considered. It is, however, not clear how one should handle a situation where multiple outbreaks are likely to occur. Here, we identify the best control strategy for such a situation. We further discuss ways in which such a strategy can be implemented to achieve additional public health objectives.},
  doi =         {10.1098/rspb.2006.0015},
  institution = {Department of Biology, Emory University, Atlanta, GA 30322, USA. ahandel@emory.edu},
  keywords =    {Communicable Disease Control; Computer Simulation; Decision Support Techniques; Disease Outbreaks, prevention /&/ control; Models, Biological},
  language =    {eng},
  medline-pst = {ppublish},
  pii =         {C7Q758640Q515247},
  pmc =         {PMC2093965},
  pmid =        {17251095},
  url =         {http://dx.doi.org/10.1098/rspb.2006.0015}
}

@Article{handel09,
  author =      {Handel, Andreas and Longini, Jr, Ira M and Antia, Rustom},
  title =       {Intervention strategies for an influenza pandemic taking into account secondary bacterial infections.},
  journal =     {Epidemics},
  year =        {2009},
  volume =      {1},
  number =      {3},
  pages =       {185--195},
  month =       {Sep},
  abstract =    {Influenza infections often predispose individuals to consecutive bacterial infections. Both during seasonal and pandemic influenza outbreaks, morbidity and mortality due to secondary bacterial infections can be substantial. With the help of a mathematical model, we investigate the potential impact of such bacterial infections during an influenza pandemic, and we analyze how antiviral and antibacterial treatment or prophylaxis affect morbidity and mortality. We consider different scenarios for the spread of bacteria, the emergence of antiviral resistance, and different levels of severity for influenza infections (1918-like and 2009-like). We find that while antibacterial intervention strategies are unlikely to play an important role in reducing the overall number of cases, such interventions can lead to a significant reduction in mortality and in the number of bacterial infections. Antibacterial interventions become even more important if one considers the--very likely--scenario that during a pandemic outbreak, influenza strains resistant to antivirals emerge. Overall, our study suggests that pandemic preparedness plans should consider intervention strategies based on antibacterial treatment or prophylaxis through drugs or vaccines as part of the overall control strategy. A major caveat for our results is the lack of data that would allow precise estimation of many of the model parameters. As our results show, this leads to very large uncertainty in model outcomes. As we discuss, precise assessment of the impact of antibacterial strategies during an influenza pandemic will require the collection of further data to better estimate key parameters, especially those related to the bacterial infections and the impact of antibacterial intervention strategies.},
  doi =         {10.1016/j.epidem.2009.09.001},
  institution = {Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA 30602, USA. ahandel@uga.edu},
  keywords =    {Anti-Bacterial Agents, therapeutic use; Antiviral Agents, therapeutic use; Bacteria, drug effects; Bacterial Infections, complications/drug therapy/epidemiology/prevention /&/ control; Computer Simulation; Drug Resistance, Viral; Humans; Influenza, Human, complications/drug therapy/epidemiology; Models, Biological; Orthomyxoviridae, drug effects; Pandemics, prevention /&/ control; United States, epidemiology},
  language =    {eng},
  medline-pst = {ppublish},
  pmc =         {PMC2796779},
  pmid =        {20161493},
  url =         {http://dx.doi.org/10.1016/j.epidem.2009.09.001}
}

@Article{handel09a,
  author =      {Handel, Andreas and Longini, Jr, Ira M and Antia, Rustom},
  title =       {Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.},
  journal =     {J Theor Biol},
  year =        {2009},
  volume =      {256},
  number =      {1},
  pages =       {117--125},
  month =       {Jan},
  abstract =    {Antiviral drugs, most notably the neuraminidase inhibitors, are an important component of control strategies aimed to prevent or limit any future influenza pandemic. The potential large-scale use of antiviral drugs brings with it the danger of drug resistance evolution. A number of recent studies have shown that the emergence of drug-resistant influenza could undermine the usefulness of antiviral drugs for the control of an epidemic or pandemic outbreak. While these studies have provided important insights, the inherently stochastic nature of resistance generation and spread, as well as the potential for ongoing evolution of the resistant strain have not been fully addressed. Here, we study a stochastic model of drug resistance emergence and consecutive evolution of the resistant strain in response to antiviral control during an influenza pandemic. We find that taking into consideration the ongoing evolution of the resistant strain does not increase the probability of resistance emergence; however, it increases the total number of infecteds if a resistant outbreak occurs. Our study further shows that taking stochasticity into account leads to results that can differ from deterministic models. Specifically, we find that rapid and strong control cannot only contain a drug sensitive outbreak, it can also prevent a resistant outbreak from occurring. We find that the best control strategy is early intervention heavily based on prophylaxis at a level that leads to outbreak containment. If containment is not possible, mitigation works best at intermediate levels of antiviral control. Finally, we show that the results are not very sensitive to the way resistance generation is modeled.},
  doi =         {10.1016/j.jtbi.2008.09.021},
  institution = {Department of Biology, Emory University, Atlanta, GA 30322, USA. andreas.handel@gmail.com},
  keywords =    {Antiviral Agents, therapeutic use; Biological Evolution; Disease Outbreaks, prevention /&/ control; Drug Resistance, Viral, genetics; Humans; Influenza A virus, drug effects/genetics; Influenza, Human, drug therapy/epidemiology/prevention /&/ control; Models, Biological; Mutation; Stochastic Processes},
  language =    {eng},
  medline-pst = {ppublish},
  pii =         {S0022-5193(08)00492-X},
  pmc =         {PMC2624577},
  pmid =        {18952105},
  url =         {http://dx.doi.org/10.1016/j.jtbi.2008.09.021}
}

@Article{handel10,
  author =      {Handel, Andreas and Longini, Jr, Ira M and Antia, Rustom},
  title =       {Towards a quantitative understanding of the within-host dynamics of influenza A infections.},
  journal =     {J R Soc Interface},
  year =        {2010},
  volume =      {7},
  number =      {42},
  pages =       {35--47},
  month =       {Jan},
  abstract =    {Although the influenza A virus has been extensively studied, a quantitative understanding of the infection dynamics is still lacking. To make progress in this direction, we designed several mathematical models and compared them with data from influenza A infections of mice. We find that the immune response (IR) plays an important part in the infection dynamics. Both an innate and an adaptive IR are required to provide adequate explanation of the data. In contrast, regrowth of epithelial cells did not seem to be an important mechanism on the time scale of the infection. We also find that different model variants for both innate and adaptive responses fit the data well, indicating the need for additional data to allow further model discrimination.},
  doi =         {10.1098/rsif.2009.0067},
  institution = {Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA 30602, USA. ahandel@uga.edu},
  keywords =    {Animals; Computer Simulation; Disease Models, Animal; Epithelial Cells, immunology/virology; Host-Pathogen Interactions, immunology; Humans; Immunity, Innate, immunology; Influenza A virus, immunology/pathogenicity/physiology; Influenza, Human, immunology/virology; Mice; Models, Immunological},
  language =    {eng},
  medline-pst = {ppublish},
  pii =         {rsif.2009.0067},
  pmc =         {PMC2839376},
  pmid =        {19474085},
  url =         {http://dx.doi.org/10.1098/rsif.2009.0067}
}

@Article{handel13,
  Title                    = {A multi-scale analysis of influenza A virus fitness trade-offs due to temperature-dependent virus persistence.},
  Author                   = {Handel, Andreas and Brown, Justin and Stallknecht, David and Rohani, Pejman},
  Journal                  = {PLoS Comput Biol},
  Year                     = {2013},
  Number                   = {3},
  Pages                    = {e1002989},
  Volume                   = {9},

  Abstract                 = {Successful replication within an infected host and successful transmission between hosts are key to the continued spread of most pathogens. Competing selection pressures exerted at these different scales can lead to evolutionary trade-offs between the determinants of fitness within and between hosts. Here, we examine such a trade-off in the context of influenza A viruses and the differential pressures exerted by temperature-dependent virus persistence. For a panel of avian influenza A virus strains, we find evidence for a trade-off between the persistence at high versus low temperatures. Combining a within-host model of influenza infection dynamics with a between-host transmission model, we study how such a trade-off affects virus fitness on the host population level. We show that conclusions regarding overall fitness are affected by the type of link assumed between the within- and between-host levels and the main route of transmission (direct or environmental). The relative importance of virulence and immune response mediated virus clearance are also found to influence the fitness impacts of virus persistence at low versus high temperatures. Based on our results, we predict that if transmission occurs mainly directly and scales linearly with virus load, and virulence or immune responses are negligible, the evolutionary pressure for influenza viruses to evolve toward good persistence at high within-host temperatures dominates. For all other scenarios, influenza viruses with good environmental persistence at low temperatures seem to be favored.},
  Doi                      = {10.1371/journal.pcbi.1002989},
  Institution              = {Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, Georgia, United States of America. ahandel@uga.edu},
  Keywords                 = {Animals; Birds; Computational Biology; Feces, virology; Genetic Fitness, physiology; Host-Pathogen Interactions; Humans; Influenza A virus, pathogenicity/physiology; Influenza, Human, transmission/virology; Models, Biological; Orthomyxoviridae Infections, transmission/virology; Temperature},
  Language                 = {eng},
  Medline-pst              = {ppublish},
  Pii                      = {PCOMPBIOL-D-12-01335},
  Pmc                      = {PMC3605121},
  Pmid                     = {23555223},
  Url                      = {http://dx.doi.org/10.1371/journal.pcbi.1002989}
}

@Article{handel14,
  Title                    = {Trade-offs between and within scales: environmental persistence and within-host fitness of avian influenza viruses.},
  Author                   = {Handel, Andreas and Lebarbenchon, Camille and Stallknecht, David and Rohani, Pejman},
  Journal                  = {Proc Biol Sci},
  Year                     = {2014},

  Month                    = {Jul},
  Number                   = {1787},
  Volume                   = {281},

  Abstract                 = {Trade-offs between different components of a pathogen's replication and transmission cycle are thought to be common. A number of studies have identified trade-offs that emerge across scales, reflecting the tension between strategies that optimize within-host proliferation and large-scale population spread. Most of these studies are theoretical in nature, with direct experimental tests of such cross-scale trade-offs still rare. Here, we report an analysis of avian influenza A viruses across scales, focusing on the phenotype of temperature-dependent viral persistence. Taking advantage of a unique dataset that reports both environmental virus decay rates and strain-specific viral kinetics from duck challenge experiments, we show that the temperature-dependent environmental decay rate of a strain does not impact within-host virus load. Hence, for this phenotype, the scales of within-host infection dynamics and between-host environmental persistence do not seem to interact: viral fitness may be optimized on each scale without cross-scale trade-offs. Instead, we confirm the existence of a temperature-dependent persistence trade-off on a single scale, with some strains favouring environmental persistence in water at low temperatures while others reduce sensitivity to increasing temperatures. We show that this temperature-dependent trade-off is a robust phenomenon and does not depend on the details of data analysis. Our findings suggest that viruses might employ different environmental persistence strategies, which facilitates the coexistence of diverse strains in ecological niches. We conclude that a better understanding of the transmission and evolutionary dynamics of influenza A viruses probably requires empirical information regarding both within-host dynamics and environmental traits, integrated within a combined ecological and within-host framework.},
  Doi                      = {10.1098/rspb.2013.3051},
  Institution              = {Department of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI 48109, USA Center for the Study of Complex Systems, University of Michigan, Ann Arbor, MI 48109, USA Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA.},
  Keywords                 = {Animals; Biological Evolution; Bird Diseases, transmission/virology; Ducks; Fresh Water, virology; Genetic Fitness; Humans; Influenza A virus, genetics/physiology; Influenza in Birds, transmission/virology; Influenza, Human, transmission/virology; Minnesota; Models, Biological; Phenotype; Temperature; Viral Load, veterinary},
  Language                 = {eng},
  Medline-pst              = {ppublish},
  Pii                      = {rspb.2013.3051},
  Pmc                      = {PMC4071531},
  Pmid                     = {24898369},
  Url                      = {http://dx.doi.org/10.1098/rspb.2013.3051}
}

@Article{handel15,
  Title                    = {Crossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledge.},
  Author                   = {Handel, Andreas and Rohani, Pejman},
  Journal                  = {Philos Trans R Soc Lond B Biol Sci},
  Year                     = {2015},

  Month                    = {Aug},
  Number                   = {1675},
  Volume                   = {370},

  Abstract                 = {The progression of an infection within a host determines the ability of a pathogen to transmit to new hosts and to maintain itself in the population. While the general connection between the infection dynamics within a host and the population-level transmission dynamics of pathogens is widely acknowledged, a comprehensive and quantitative understanding that would allow full integration of the two scales is still lacking. Here, we provide a brief discussion of both models and data that have attempted to provide quantitative mappings from within-host infection dynamics to transmission fitness. We present a conceptual framework and provide examples of studies that have taken first steps towards development of a quantitative framework that scales from within-host infections to population-level fitness of different pathogens. We hope to illustrate some general themes, summarize some of the recent advances and-maybe most importantly-discuss gaps in our ability to bridge these scales, and to stimulate future research on this important topic.},
  Doi                      = {10.1098/rstb.2014.0302},
  Institution              = {Department of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI 48109, USA Center for the Study of Complex Systems, University of Michigan, Ann Arbor, MI 48109, USA Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA.},
  Keywords                 = {Animals; HIV Infections, transmission; Host-Pathogen Interactions; Humans; Infection, transmission; Influenza, Human, transmission; Models, Biological},
  Language                 = {eng},
  Medline-pst              = {ppublish},
  Pii                      = {rstb.2014.0302},
  Pmc                      = {PMC4528500},
  Pmid                     = {26150668},
  Url                      = {http://dx.doi.org/10.1098/rstb.2014.0302}
}

@Article{handel06,
  author    = {Handel, Andreas and Regoes, Roland R. and Antia, Rustom},
  title     = {The role of compensatory mutations in the emergence of drug resistance},
  journal   = {PLoS computational biology},
  year      = {2006},
  volume    = {2},
  number    = {10},
  pages     = {e137},
  file      = {handel06ploscomp - The Role of Compensatory Mutations in the Emergence of Drug Resistance.pdf:C\:\\Users\\andreas\\AppData\\Roaming\\Mozilla\\Firefox\\Profiles\\7pcgpjzx.default\\zotero\\storage\\FENCCQ6D\\handel06ploscomp - The Role of Compensatory Mutations in the Emergence of Drug Resistance.pdf:application/pdf},
  owner     = {andreas},
  timestamp = {2017.08.08},
  url       = {http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.0020137},
  urldate   = {2017-08-08},
}

@Article{king09a,
  author    = {King, A and Ionides, E and Bret{\'o}, C and Ellner, S and Kendall, B},
  title     = {POMP: Statistical inference for partially observed Markov processes (R package). h ttp},
  journal   = {pomp. r-forge. r-rproject. org},
  year      = {2009},
  owner     = {andreas},
  timestamp = {2017.09.18},
}

@Article{beauchemin11,
  author       = {Beauchemin, Catherine A A. and Handel, Andreas},
  title        = {A review of mathematical models of influenza {A} infections within a host or cell culture: lessons learned and challenges ahead.},
  volume       = {11 Suppl 1},
  number       = {Suppl 1},
  pages        = {S7},
  date         = {2011},
  doi          = {10.1186/1471-2458-11-S1-S7},
  file         = {Beauchemin_2011_BMC-PubHealth.pdf:C:UsersScottDropboxPapersZoterostorage7MSKSUWMBeauchemin_2011_BMC-PubHealth.pdf},
  journaltitle = {BMC Public Health},
  language     = {eng},
  medline-pst  = {epublish},
  owner        = {andreas},
  pii          = {1471-2458-11-S1-S7},
  pmid         = {21356136},
  shorttitle   = {A review of mathematical models of influenza A infections within a host or cell culture},
  timestamp    = {2011.10.13},
}

@Article{bell70,
  author    = {Bell, George I},
  title     = {Mathematical model of clonal selection and antibody production},
  journal   = {Journal of theoretical biology},
  year      = {1970},
  volume    = {29},
  number    = {2},
  pages     = {191--232},
  owner     = {andreas},
  publisher = {Elsevier},
  timestamp = {2017.09.18},
}

@Article{bell71,
  author    = {Bell, George I},
  title     = {Mathematical model of clonal selection and antibody production. II},
  journal   = {Journal of theoretical biology},
  year      = {1971},
  volume    = {33},
  number    = {2},
  pages     = {339--378},
  owner     = {andreas},
  publisher = {Elsevier},
  timestamp = {2017.09.18},
}

@Article{bell71a,
  author    = {Bell, George I},
  title     = {Mathematical model of clonal selection and antibody production III. The cellular basis of immunological paralysis},
  journal   = {Journal of theoretical biology},
  year      = {1971},
  volume    = {33},
  number    = {2},
  pages     = {379--398},
  owner     = {andreas},
  publisher = {Elsevier},
  timestamp = {2017.09.18},
}

@Article{dobrovolny13,
  author       = {Dobrovolny, Hana M. and Reddy, Micaela B. and Kamal, Mohamed A. and Rayner, Craig R. and Beauchemin, Catherine A. A.},
  title        = {Assessing Mathematical Models of Influenza Infections Using Features of the Immune Response},
  volume       = {8},
  number       = {2},
  pages        = {e57088},
  date         = {2013-02},
  doi          = {10.1371/journal.pone.0057088},
  file         = {Full Text PDF:C:UsersandreasAppDataRoamingMozillaFirefoxProfiles6zk3bj0w.defaultzoterostorage55W694PFDobrovolny et al. - 2013 - Assessing Mathematical Models of Influenza Infecti.pdf;Snapshot:C:UsersandreasAppDataRoamingMozillaFirefoxProfiles6zk3bj0w.defaultzoterostorageATRSD5JIinfodoi10.1371journal.pone.html},
  issn         = {1932-6203},
  journaltitle = {{PLOS} {ONE}},
  owner        = {andreas},
  timestamp    = {2013.03.27},
  url          = {http://www.plosone.org/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0057088;jsessionid=C9BC86B0ED5AFDED68462783703C784F},
  urldate      = {2013-03-27},
}

@Article{ho95,
  author        = {D. D. Ho and A. U. Neumann and A. S. Perelson and W. Chen and J. M. Leonard and M. Markowitz},
  title         = {{Rapid turnover of plasma virions and {CD}4 lymphocytes in {HIV}-1 infection}},
  volume        = {373},
  number        = {6510},
  pages         = {123--126},
  bdsk-url-1    = {http://dx.doi.org/10.1038/373123a0},
  bdsk-url-2    = {http://dx.doi.org/10.1038/373123a0},
  date          = {1995-01},
  date-modified = {2008-03-06 11:52:25 -0500},
  doi           = {10.1038/373123a0},
  journaltitle  = {Nature},
  owner         = {andreas},
  pmid          = {7746321},
  timestamp     = {2006.01.09},
}

@Article{kirschner05,
  author        = {Denise Kirschner and Simeone Marino},
  title         = {{Mycobacterium tuberculosis as viewed through a computer}},
  volume        = {13},
  number        = {5},
  pages         = {206--211},
  bdsk-url-1    = {http://dx.doi.org/10.1016/j.tim.2005.03.005},
  bdsk-url-2    = {http://dx.doi.org/10.1016/j.tim.2005.03.005},
  date          = {2005-05},
  date-modified = {2008-03-06 11:51:43 -0500},
  doi           = {10.1016/j.tim.2005.03.005},
  journaltitle  = {Trends Microbiol},
  owner         = {andreas},
  pii           = {S0966-842X(05)00075-2},
  pmid          = {15866037},
  timestamp     = {2008.02.21},
}

@Article{larson76,
  author        = {E. W. Larson and J. W. Dominik and A. H. Rowberg and G. A. Higbee},
  title         = {{{I}nfluenza virus population dynamics in the respiratory tract of experimentally infected mice}},
  volume        = {13},
  number        = {2},
  pages         = {438--447},
  date          = {1976-02},
  date-modified = {2008-03-06 11:50:59 -0500},
  journaltitle  = {Infect Immun},
  owner         = {andreas},
  pmid          = {1262060},
  timestamp     = {2006.12.20},
}

@Article{mideo08c,
  author       = {Nicole Mideo and Troy Day and Andrew F Read},
  title        = {Modelling malaria pathogenesis.},
  volume       = {10},
  number       = {10},
  pages        = {1947--1955},
  date         = {2008-10},
  doi          = {10.1111/j.1462-5822.2008.01208.x},
  institution  = {Department of Biology, Queen's University, Kingston, ON, Canada. 4nlm@queensu.ca},
  journaltitle = {Cell Microbiol},
  owner        = {andreas},
  pii          = {CMI1208},
  pmid         = {18647174},
  timestamp    = {2010.01.30},
}

@Article{neumann98,
  author        = {A. U. Neumann and N. P. Lam and H. Dahari and D. R. Gretch and T. E. Wiley and T. J. Layden and A. S. Perelson},
  title         = {{Hepatitis {C} viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy}},
  volume        = {282},
  number        = {5386},
  pages         = {103--107},
  date          = {1998-10},
  date-modified = {2008-03-06 11:50:35 -0500},
  journaltitle  = {Science},
  owner         = {andreas},
  pmid          = {9756471},
  timestamp     = {2006.01.09},
}

@Article{perelson96,
  author        = {A. S. Perelson and A. U. Neumann and M. Markowitz and J. M. Leonard and D. D. Ho},
  title         = {{H{IV}-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time}},
  volume        = {271},
  number        = {5255},
  pages         = {1582--1586},
  date          = {1996-03},
  date-modified = {2008-03-06 11:50:40 -0500},
  journaltitle  = {Science},
  owner         = {andreas},
  pmid          = {8599114},
  timestamp     = {2006.01.09},
}

@Article{smith11,
  author       = {Amber M Smith and Alan S Perelson},
  title        = {Influenza A virus infection kinetics: quantitative data and models.},
  volume       = {3},
  number       = {4},
  pages        = {429--445},
  date         = {2011-07},
  doi          = {10.1002/wsbm.129},
  institution  = {Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, USA.},
  journaltitle = {Wiley Interdiscip Rev Syst Biol Med},
  language     = {eng},
  medline-pst  = {ppublish},
  owner        = {andreas},
  pmid         = {21197654},
  timestamp    = {2011.07.14},
}

@Article{perelson02,
  author          = {Perelson, Alan S},
  title           = {Modelling viral and immune system dynamics.},
  journal         = {Nature reviews. Immunology},
  year            = {2002},
  volume          = {2},
  pages           = {28--36},
  month           = jan,
  issn            = {1474-1733},
  abstract        = {During the past 6 years, there have been substantial advances in our understanding of human immunodeficiency virus 1 and other viruses, such as hepatitis B virus and hepatitis C virus, that cause chronic infection. The use of mathematical modelling to interpret experimental results has made a significant contribution to this field. Mathematical modelling is also improving our understanding of T-cell dynamics and the quantitative events that underlie the immune response to pathogens.},
  chemicals       = {Anti-HIV Agents},
  citation-subset = {IM},
  completed       = {2002-04-11},
  country         = {England},
  doi             = {10.1038/nri700},
  issn-linking    = {1474-1733},
  issue           = {1},
  keywords        = {Animals; Anti-HIV Agents, therapeutic use; HIV Infections, drug therapy, immunology, virology; HIV-1, drug effects, isolation & purification, physiology; Hepatitis B, immunology; Hepatitis C, immunology; Humans; Models, Immunological; T-Lymphocytes, immunology, pathology; Virus Diseases, immunology, virology; Virus Replication, drug effects, immunology},
  nlm-id          = {101124169},
  owner           = {NLM},
  pmid            = {11905835},
  pubmodel        = {Print},
  pubstatus       = {ppublish},
  references      = {101},
  revised         = {2006-11-15},
  timestamp       = {2018.06.19},
}

@Book{anderson91,
  author        = {R. M. Anderson and R. M. May},
  publisher     = {Oxford Science Publications},
  title         = {{Infectious Diseases of Humans - Dynamics and Control}},
  date          = {1991},
  date-modified = {2008-03-06 11:50:54 -0500},
  location      = {Oxford},
  owner         = {andreas},
  timestamp     = {2018.06.19},
}

@Article{antia96a,
  author        = {Antia, R. and Koella, J.C. and Perrot, V.},
  title         = {{Models of the within-host dynamics of persistent mycobacterial infections}},
  volume        = {263},
  number        = {1368},
  pages         = {257--63},
  authoraddress = {Department of Biology, Emory University, Atlanta, Georgia 30322, USA.},
  date          = {1996},
  date-modified = {2008-03-06 11:51:32 -0500},
  journaltitle  = {Proc Biol Sci},
  language      = {eng},
  medline-da    = {19970107},
  medline-dcom  = {19970107},
  medline-edat  = {1996/03/22},
  medline-fau   = {Antia, R ; Koella, J C ; Perrot, V},
  medline-is    = {0962-8452},
  medline-jid   = {101245157},
  medline-lr    = {20050408},
  medline-mhda  = {1996/03/22 00:01},
  medline-own   = {NLM},
  medline-pl    = {ENGLAND},
  medline-pmid  = {8920248},
  medline-pst   = {ppublish},
  medline-pt    = {Journal Article},
  medline-pubm  = {Print},
  medline-sb    = {IM},
  medline-so    = {Proc Biol Sci 1996 Mar 22;263(1368):257-63.},
  medline-stat  = {MEDLINE},
  owner         = {andreas},
  timestamp     = {2018.06.19},
}

@Article{antia05,
  author        = {Rustom Antia and Vitaly V Ganusov and Rafi Ahmed},
  title         = {{The role of models in understanding {CD}8+ {T}-cell memory}},
  volume        = {5},
  number        = {2},
  pages         = {101--111},
  bdsk-url-1    = {http://dx.doi.org/10.1038/nri1550},
  bdsk-url-2    = {http://dx.doi.org/10.1038/nri1550},
  date          = {2005},
  date-modified = {2008-03-06 11:53:26 -0500},
  doi           = {10.1038/nri1550},
  journaltitle  = {Nat Rev Immunol},
  owner         = {andreas},
  pii           = {nri1550},
  pmid          = {15662368},
  timestamp     = {2005.12.13},
}

@Book{nowak01,
  author    = {Nowak, Martin A. and May, Robert M.},
  publisher = {Oxford University Press},
  title     = {Virus {Dynamics}: {Mathematical} principles of immunology and virology},
  year      = {2001},
  owner     = {andreas},
  timestamp = {2018.06.19},
}

@Book{wodarz07,
  author    = {Wodarz, Dominik},
  publisher = {Springer},
  title     = {Killer cell dynamics mathematical and computational approaches to immunology},
  year      = {2007},
  address   = {New York},
  abstract  = {"This book reviews how mathematics can be used in combination with biological data in order to improve understanding of how the immune system works. This is illustrated largely in the context of viral infections. Mathematical models allow scientists to capture complex biological interactions in a clear mathematical language and to follow them to their precise logical conclusions. This can give rise to counter-intuitive insights which would not be attained by experiments alone, and can be used for the design of further experiments in order to address the mathematical results."--Jacket.},
  isbn      = {978-0-387-68733-9 0-387-68733-5 0-387-30893-8 978-0-387-30893-7},
  language  = {English},
  owner     = {andreas},
  timestamp = {2018.06.19},
  url       = {http://public.eblib.com/EBLPublic/PublicView.do?ptiID=302146},
  urldate   = {2013-10-07},
}

@Book{keeling08,
  author    = {Keeling, Matt J and Rohani, Pejman},
  publisher = {Princeton University Press},
  title     = {Modeling infectious diseases in humans and animals},
  year      = {2008},
  owner     = {andreas},
  timestamp = {2015.09.11},
}

@Book{vynnycky10,
  author    = {Vynnycky, Emilia and White, Richard},
  publisher = {Oxford University Press},
  title     = {An introduction to infectious disease modelling},
  year      = {2010},
  owner     = {andreas},
  timestamp = {2017.02.20},
}

@Article{fine11,
  author          = {Fine, Paul and Eames, Ken and Heymann, David L},
  title           = {"Herd immunity": a rough guide.},
  journal         = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year            = {2011},
  volume          = {52},
  pages           = {911--916},
  month           = apr,
  issn            = {1537-6591},
  abstract        = {The term "herd immunity" is widely used but carries a variety of meanings. Some authors use it to describe the proportion immune among individuals in a population. Others use it with reference to a particular threshold proportion of immune individuals that should lead to a decline in incidence of infection. Still others use it to refer to a pattern of immunity that should protect a population from invasion of a new infection. A common implication of the term is that the risk of infection among susceptible individuals in a population is reduced by the presence and proximity of immune individuals (this is sometimes referred to as "indirect protection" or a "herd effect"). We provide brief historical, epidemiologic, theoretical, and pragmatic public health perspectives on this concept.},
  citation-subset = {IM},
  completed       = {2011-07-18},
  country         = {United States},
  created         = {2011-03-23},
  doi             = {10.1093/cid/cir007},
  issn-linking    = {1058-4838},
  issue           = {7},
  keywords        = {Communicable Disease Control; Communicable Diseases, immunology, transmission; Disease Transmission, Infectious, prevention & control; Humans; Immunity, Herd; Terminology as Topic},
  nlm-id          = {9203213},
  owner           = {NLM},
  pii             = {cir007},
  pmid            = {21427399},
  pubmodel        = {Print},
  pubstatus       = {ppublish},
  revised         = {2011-03-23},
  timestamp       = {2017.02.20},
}

@Article{heffernan05a,
  author          = {Heffernan, J M and Smith, R J and Wahl, L M},
  title           = {Perspectives on the basic reproductive ratio.},
  journal         = {Journal of the Royal Society, Interface},
  year            = {2005},
  volume          = {2},
  pages           = {281--293},
  month           = sep,
  issn            = {1742-5689},
  abstract        = {The basic reproductive ratio, R0, is defined as the expected number of secondary infections arising from a single individual during his or her entire infectious period, in a population of susceptibles. This concept is fundamental to the study of epidemiology and within-host pathogen dynamics. Most importantly, R0 often serves as a threshold parameter that predicts whether an infection will spread. Related parameters which share this threshold behaviour, however, may or may not give the true value of R0. In this paper we give a brief overview of common methods of formulating R0 and surrogate threshold parameters from deterministic, non-structured models. We also review common means of estimating R0 from epidemiological data. Finally, we survey the recent use of R0 in assessing emerging diseases, such as severe acute respiratory syndrome and avian influenza, a number of recent livestock diseases, and vector-borne diseases malaria, dengue and West Nile virus.},
  citation-subset = {IM},
  completed       = {2006-08-16},
  country         = {England},
  created         = {2006-07-19},
  doi             = {10.1098/rsif.2005.0042},
  issn-linking    = {1742-5662},
  issue           = {4},
  keywords        = {Animals; Communicable Diseases, Emerging, epidemiology; Computer Simulation; Disease Outbreaks, statistics & numerical data; Disease Susceptibility, epidemiology; Disease Transmission, Infectious, statistics & numerical data; Epidemiologic Methods; Humans; Incidence; Models, Biological; Population Dynamics; Prevalence; Risk Assessment, methods; Risk Factors},
  nlm             = {PMC1578275},
  nlm-id          = {101217269},
  owner           = {NLM},
  pii             = {KJ2U12Q2WMNF2W1E},
  pmc             = {PMC1578275},
  pmid            = {16849186},
  pubmodel        = {Print},
  pubstatus       = {ppublish},
  references      = {77},
  revised         = {2016-10-20},
  timestamp       = {2017.02.20},
}

@Article{roberts07,
  author          = {Roberts, M G},
  title           = {The pluses and minuses of R0.},
  journal         = {Journal of the Royal Society, Interface},
  year            = {2007},
  volume          = {4},
  pages           = {949--961},
  month           = oct,
  issn            = {1742-5689},
  abstract        = {The concept of the basic reproduction number (R0) occupies a central place in epidemic theory. The value of R0 determines the proportion of the population that becomes infected over the course of a (modelled) epidemic. In many models, (i) an endemic infection can persist only if R0>1, (ii) the value of R0 provides a direct measure of the control effort required to eliminate the infection, and (iii) pathogens evolve to maximize their value of R0. These three statements are not universally true. In this paper, some exceptions to them are discussed, based on the extensions of the SIR model.},
  citation-subset = {IM},
  completed       = {2007-11-13},
  country         = {England},
  created         = {2007-09-13},
  doi             = {10.1098/rsif.2007.1031},
  issn-linking    = {1742-5662},
  issue           = {16},
  keywords        = {Animal Diseases, epidemiology; Animals; Animals, Wild; Communicable Diseases, epidemiology; Disease Transmission, Infectious, statistics & numerical data; Models, Biological; Models, Statistical},
  nlm             = {PMC2075534},
  nlm-id          = {101217269},
  owner           = {NLM},
  pii             = {P368100327733485},
  pmc             = {PMC2075534},
  pmid            = {17490942},
  pubmodel        = {Print},
  pubstatus       = {ppublish},
  revised         = {2016-10-20},
  timestamp       = {2017.02.20},
}

@Article{beauchemin11a,
  author    = {Beauchemin, Catherine AA and Handel, Andreas},
  title     = {A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead},
  journal   = {BMC public health},
  year      = {2011},
  volume    = {11},
  number    = {1},
  pages     = {S7},
  owner     = {andreas},
  publisher = {BioMed Central},
  timestamp = {2018.04.09},
}

@Article{dobrovolny13a,
  author    = {Dobrovolny, Hana M and Reddy, Micaela B and Kamal, Mohamed A and Rayner, Craig R and Beauchemin, Catherine AA},
  title     = {Assessing mathematical models of influenza infections using features of the immune response},
  journal   = {PloS one},
  year      = {2013},
  volume    = {8},
  number    = {2},
  pages     = {e57088},
  owner     = {andreas},
  publisher = {Public Library of Science},
  timestamp = {2018.04.09},
}

@Article{perelson13,
  author    = {Perelson, Alan S and Ribeiro, Ruy M},
  title     = {Modeling the within-host dynamics of HIV infection},
  journal   = {BMC biology},
  year      = {2013},
  volume    = {11},
  number    = {1},
  pages     = {96},
  owner     = {andreas},
  publisher = {BioMed Central},
  timestamp = {2018.04.09},
}

@Article{beauchemin08,
  author          = {Beauchemin, Catherine A A and McSharry, James J and Drusano, George L and Nguyen, Jack T and Went, Gregory T and Ribeiro, Ruy M and Perelson, Alan S},
  title           = {Modeling amantadine treatment of influenza A virus in vitro.},
  journal         = {Journal of theoretical biology},
  year            = {2008},
  volume          = {254},
  pages           = {439--451},
  month           = sep,
  issn            = {1095-8541},
  abstract        = {We analyzed the dynamics of an influenza A/Albany/1/98 (H3N2) viral infection, using a set of mathematical models highlighting the differences between in vivo and in vitro infection. For example, we found that including virion loss due to cell entry was critical for the in vitro model but not for the in vivo model. Experiments were performed on influenza virus-infected MDCK cells in vitro inside a hollow-fiber (HF) system, which was used to continuously deliver the drug amantadine. The HF system captures the dynamics of an influenza infection, and is a controlled environment for producing experimental data which lend themselves well to mathematical modeling. The parameter estimates obtained from fitting our mathematical models to the HF experimental data are consistent with those obtained earlier for a primary infection in a human model. We found that influenza A/Albany/1/98 (H3N2) virions under normal experimental conditions at 37 degrees C rapidly lose infectivity with a half-life of approximately 6.6+/-0.2 h, and that the lifespan of productively infected MDCK cells is approximately 13 h. Finally, using our models we estimated that the maximum efficacy of amantadine in blocking viral infection is approximately 74%, and showed that this low maximum efficacy is likely due to the rapid development of drug resistance.},
  chemicals       = {Amantadine},
  citation-subset = {IM},
  completed       = {2008-12-05},
  country         = {England},
  doi             = {10.1016/j.jtbi.2008.05.031},
  issn-linking    = {0022-5193},
  issue           = {2},
  keywords        = {Amantadine, therapeutic use; Animals; Cell Death; Cell Line; Dogs; Drug Resistance, Viral; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza A virus; Kidney, virology; Models, Biological; Orthomyxoviridae Infections, drug therapy, virology; Time Factors; Virion; Virology, instrumentation, methods; Virulence},
  mid             = {NIHMS70313},
  nlm-id          = {0376342},
  owner           = {NLM},
  pii             = {S0022-5193(08)00279-8},
  pmc             = {PMC2663526},
  pmid            = {18653201},
  pubmodel        = {Print-Electronic},
  pubstatus       = {ppublish},
  revised         = {2016-11-22},
  timestamp       = {2018.04.09},
}

@Article{baccam06,
  author          = {Baccam, Prasith and Beauchemin, Catherine and Macken, Catherine A and Hayden, Frederick G and Perelson, Alan S},
  title           = {Kinetics of influenza A virus infection in humans.},
  journal         = {Journal of virology},
  year            = {2006},
  volume          = {80},
  pages           = {7590--7599},
  month           = aug,
  issn            = {0022-538X},
  abstract        = {Currently, little is known about the viral kinetics of influenza A during infection within an individual. We utilize a series of mathematical models of increasing complexity, which incorporate target cell limitation and the innate interferon response, to examine influenza A virus kinetics in the upper respiratory tracts of experimentally infected adults. The models were fit to data from an experimental H1N1 influenza A/Hong Kong/123/77 infection and suggest that it is important to include the eclipse phase of the viral life cycle in viral dynamic models. Doing so, we estimate that after a delay of approximately 6 h, infected cells begin producing influenza virus and continue to do so for approximately 5 h. The average lifetime of infected cells is approximately 11 h, and the half-life of free infectious virus is approximately 3 h. We calculated the basic reproductive number, R(0), which indicated that a single infected cell could produce approximately 22 new productive infections. This suggests that antiviral treatments have a large hurdle to overcome in moderating symptoms and limiting infectiousness and that treatment has to be initiated as early as possible. For about 50% of patients, the curve of viral titer versus time has two peaks. This bimodal behavior can be explained by incorporating the antiviral effects of interferon into the model. Our model also compared well to an additional data set on viral titer after experimental infection and treatment with the neuraminidase inhibitor zanamivir, which suggests that such models may prove useful in estimating the efficacies of different antiviral therapies for influenza A infection.},
  chemicals       = {Antiviral Agents, Guanidines, Pyrans, Sialic Acids, Interferons, Zanamivir},
  citation-subset = {IM},
  completed       = {2006-08-18},
  country         = {United States},
  doi             = {10.1128/JVI.01623-05},
  issn-linking    = {0022-538X},
  issue           = {15},
  keywords        = {Administration, Intranasal; Adult; Antiviral Agents, therapeutic use; Guanidines, therapeutic use; Humans; Influenza A Virus, H1N1 Subtype, isolation & purification, physiology; Influenza, Human, drug therapy, virology; Interferons, pharmacology; Kinetics; Models, Theoretical; Nose, virology; Pyrans, therapeutic use; Sialic Acids, therapeutic use; Zanamivir},
  nlm-id          = {0113724},
  owner           = {NLM},
  pii             = {80/15/7590},
  pmc             = {PMC1563736},
  pmid            = {16840338},
  pubmodel        = {Print},
  pubstatus       = {ppublish},
  revised         = {2016-12-03},
  timestamp       = {2018.04.09},
}

@Article{handel09b,
  author          = {Handel, Andreas and Margolis, Elisa and Levin, Bruce R},
  title           = {Exploring the role of the immune response in preventing antibiotic resistance.},
  journal         = {Journal of theoretical biology},
  year            = {2009},
  volume          = {256},
  pages           = {655--662},
  month           = feb,
  issn            = {1095-8541},
  abstract        = {For many bacterial infections, drug resistant mutants are likely present by the time antibiotic treatment starts. Nevertheless, such infections are often successfully cleared. It is commonly assumed that this is due to the combined action of drug and immune response, the latter facilitating clearance of the resistant population. However, most studies of drug resistance emergence during antibiotic treatment focus almost exclusively on the dynamics of bacteria and the drug and neglect the contribution of immune defenses. Here, we develop and analyze several mathematical models that explicitly include an immune response. We consider different types of immune responses and investigate how each impacts the emergence of resistance. We show that an immune response that retains its strength despite a strong drug-induced decline of bacteria numbers considerably reduces the emergence of resistance, narrows the mutant selection window, and mitigates the effects of non-adherence to treatment. Additionally, we show that compared to an immune response that kills bacteria at a constant rate, one that trades reduced killing at high bacterial load for increased killing at low bacterial load is sometimes preferable. We discuss the predictions and hypotheses derived from this study and how they can be tested experimentally.},
  chemicals       = {Anti-Bacterial Agents},
  citation-subset = {IM},
  completed       = {2009-04-02},
  country         = {England},
  doi             = {10.1016/j.jtbi.2008.10.025},
  issn-linking    = {0022-5193},
  issue           = {4},
  keywords        = {Anti-Bacterial Agents, therapeutic use; Bacteria, drug effects, genetics, growth & development, immunology; Bacterial Infections, drug therapy, immunology, microbiology; Drug Administration Schedule; Drug Resistance, Bacterial, immunology; Drug Resistance, Microbial, immunology; Humans; Immunity, Cellular; Models, Immunological; Mutation; Patient Compliance; Selection, Genetic},
  mid             = {NIHMS918709},
  nlm-id          = {0376342},
  owner           = {NLM},
  pii             = {S0022-5193(08)00575-4},
  pmc             = {PMC5814249},
  pmid            = {19056402},
  pubmodel        = {Print-Electronic},
  pubstatus       = {ppublish},
  revised         = {2018-02-17},
  timestamp       = {2018.06.20},
}

@Article{hayden96,
  author          = {Hayden, F G and Treanor, J J and Betts, R F and Lobo, M and Esinhart, J D and Hussey, E K},
  title           = {Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.},
  journal         = {JAMA},
  year            = {1996},
  volume          = {275},
  pages           = {295--299},
  issn            = {0098-7484},
  abstract        = {The current study evaluated whether intranasal administration of the sialic acid analog 4-guanidino-Neu5Ac2en (GG167), an inhibitor of influenza virus neuraminidase, was effective and safe in either preventing or treating experimental human influenza. Four randomized, double-blind, placebo-controlled trials involving three prophylaxis limbs, two early treatment limbs, and one delayed treatment limb were conducted. Isolation in individual rooms. Susceptible (serum hemagglutination-inhibition antibody titer < or = 1:8) adult volunteers (n = 166) were inoculated intranasally with 10(5) TCID50 influenza A/Texas/91 (H1N1) virus. GG167, 3.6 to 16 mg, was administered intranasally two or six times daily beginning 4 hours before inoculation (prophylaxis) or 1 or 2 days afterward (early or delayed treatment). Virological measures were frequency of infection based on viral shedding and/or seroconversion (prophylaxis) or quantitative viral shedding based on titers and duration of virus recovery (treatment). Clinical measures were the frequency of febrile illness and symptom severity scores. Intranasal GG167 was well tolerated for both prophylaxis and therapy. For all dose groups combined, GG167 prophylaxis was 82% effective in preventing laboratory evidence of infection and 95% effective in preventing febrile illness (P < .01 vs placebo). Early treatment with GG167 reduced peak viral titers by 2.0 log10, the median duration of viral shedding by 3 days, and the frequency of febrile illness by 85% (P < .05 for each comparison). Other measures of illness were reduced by approximately 50% to 70% in the GG167 dosing groups. Twice daily dosing was as effective as six times daily. Direct respiratory administration of the selective neuraminidase inhibitor GG167 appears safe and effective for both prevention and early treatment of experimental influenza. Influenza virus neuraminidase is important for viral replication in humans.},
  chemicals       = {Enzyme Inhibitors, Guanidines, Pyrans, Sialic Acids, Neuraminidase, Zanamivir},
  citation-subset = {AIM, IM},
  completed       = {1996-02-14},
  country         = {United States},
  issn-linking    = {0098-7484},
  issue           = {4},
  keywords        = {Administration, Intranasal; Adult; Double-Blind Method; Enzyme Inhibitors, therapeutic use; Female; Guanidines; Humans; Influenza A virus, drug effects, enzymology; Influenza, Human, drug therapy, prevention & control; Male; Neuraminidase, antagonists & inhibitors; Pyrans; Sialic Acids, administration & dosage, adverse effects, therapeutic use; Virus Shedding, drug effects; Zanamivir},
  nlm-id          = {7501160},
  owner           = {NLM},
  pmid            = {8544269},
  pubmodel        = {Print},
  pubstatus       = {ppublish},
  revised         = {2016-10-17},
  timestamp       = {2018.05.11},
}

@Book{otto11,
  author    = {Otto, Sarah P and Day, Troy},
  publisher = {Princeton University Press},
  title     = {A biologist's guide to mathematical modeling in ecology and evolution},
  year      = {2011},
  owner     = {andreas},
  timestamp = {2018.05.15},
}

@Article{antia96,
  author          = {Antia, R and Koella, J C and Perrot, V},
  title           = {Models of the within-host dynamics of persistent mycobacterial infections.},
  journal         = {Proceedings. Biological sciences},
  year            = {1996},
  volume          = {263},
  pages           = {257--263},
  month           = mar,
  issn            = {0962-8452},
  abstract        = {We use mathematical models to investigate the within-host dynamics of mycobacterial infections. In particular, we investigate the mechanisms by which bacteria such as Mycobacterium tuberculosis and Mycobacterium leprae persist at low densities for extended periods, and attain high densities much later. We suggest that the persistence of bacteria in face of immune pressure may result from the bacteria having a very slow growth rate, or having a dormant stage. We show that whereas these mechanisms may lead to long-term persistence, this will be obtained at relatively low densities. We then suggest that the long-term persistence of bacteria may result in the loss of immunity because of the deletion of specific T-cells arriving from the thymus, and the exhaustion of the specific T-cells as these cells reach the Hayflick limit and die. This loss of immunity will allow the bacteria to attain a high density. We propose experiments capable of testing our models and discuss the implications of the models for the treatment of infected hosts.},
  citation-subset = {IM},
  completed       = {1997-01-07},
  country         = {England},
  doi             = {10.1098/rspb.1996.0040},
  issn-linking    = {0962-8452},
  issue           = {1368},
  keywords        = {Humans; Leprosy, drug therapy, etiology, microbiology; Mathematics; Models, Biological; Mycobacterium Infections, etiology, microbiology; Mycobacterium leprae, growth & development, immunology; Mycobacterium tuberculosis, growth & development, immunology; Time Factors; Tuberculosis, drug therapy, etiology, microbiology},
  nlm-id          = {101245157},
  owner           = {NLM},
  pmid            = {8920248},
  pubmodel        = {Print},
  pubstatus       = {ppublish},
  revised         = {2016-10-18},
  timestamp       = {2018.05.15},
}

@Article{li14,
  author          = {Li, Yan and Handel, Andreas},
  title           = {Modeling inoculum dose dependent patterns of acute virus infections.},
  journal         = {Journal of theoretical biology},
  year            = {2014},
  volume          = {347},
  pages           = {63--73},
  month           = apr,
  issn            = {1095-8541},
  abstract        = {Inoculum dose, i.e. the number of pathogens at the beginning of an infection, often affects key aspects of pathogen and immune response dynamics. These in turn determine clinically relevant outcomes, such as morbidity and mortality. Despite the general recognition that inoculum dose is an important component of infection outcomes, we currently do not understand its impact in much detail. This study is intended to start filling this knowledge gap by analyzing inoculum dependent patterns of viral load dynamics in acute infections. Using experimental data for adenovirus and infectious bronchitis virus infections as examples, we demonstrate inoculum dose dependent patterns of virus dynamics. We analyze the data with the help of mathematical models to investigate what mechanisms can reproduce the patterns observed in experimental data. We find that models including components of both the innate and adaptive immune response are needed to reproduce the patterns found in the data. We further analyze which types of innate or adaptive immune response models agree with observed data. One interesting finding is that only models for the adaptive immune response that contain growth terms partially independent of viral load can properly reproduce observed patterns. This agrees with the idea that an antigen-independent, programmed response is part of the adaptive response. Our analysis provides useful insights into the types of model structures that are required to properly reproduce observed virus dynamics for varying inoculum doses. We suggest that such models should be taken as basis for future models of acute viral infections. },
  citation-subset = {IM},
  completed       = {2014-10-29},
  country         = {England},
  doi             = {10.1016/j.jtbi.2014.01.008},
  issn-linking    = {0022-5193},
  keywords        = {CD8-Positive T-Lymphocytes, immunology; Immunity, Innate; Models, Biological; Viral Load; Virus Diseases, immunology, physiopathology; Immune response dynamics; Within-host model},
  nlm-id          = {0376342},
  owner           = {NLM},
  pii             = {S0022-5193(14)00017-4},
  pmid            = {24440713},
  pubmodel        = {Print-Electronic},
  pubstatus       = {ppublish},
  revised         = {2014-03-10},
  timestamp       = {2018.05.15},
}

@Article{chatterjee12,
  author          = {Chatterjee, Anushree and Guedj, Jeremie and Perelson, Alan S},
  title           = {Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents?},
  journal         = {Antiviral therapy},
  year            = {2012},
  volume          = {17},
  pages           = {1171--1182},
  issn            = {2040-2058},
  __markedentry   = {[andreas:]},
  abstract        = {HCV infection is a major cause of chronic liver disease and affects nearly 170 million people worldwide. Whereas the previous standard of care with pegylated interferon and ribavirin had a modest effectiveness, the recent approval of two highly potent protease inhibitors and the ongoing development of dozens of direct-acting antiviral agents (DAAs) constitute a major milestone for HCV therapy. Mathematical modelling of viral kinetics under treatment has played an instrumental role in improving our understanding of virus pathogenesis and in guiding drug development. Here, we review the current state of HCV kinetic modelling, and challenges to the standard biphasic viral decline model that arise when fitting viral kinetic models to data obtained with DAAs.},
  chemicals       = {Antiviral Agents, Protease Inhibitors},
  citation-subset = {IM},
  completed       = {2013-08-13},
  country         = {England},
  doi             = {10.3851/IMP2428},
  issn-linking    = {1359-6535},
  issue           = {6 Pt B},
  keywords        = {Antiviral Agents, pharmacology, therapeutic use; Drug Resistance, Viral; Hepacivirus, drug effects, physiology; Hepatitis C, Chronic, complications, drug therapy, virology; Humans; Kinetics; Models, Biological; Protease Inhibitors, pharmacology, therapeutic use; Viral Load, drug effects; Virus Replication, drug effects},
  mid             = {NIHMS460955},
  nlm-id          = {9815705},
  owner           = {NLM},
  pmc             = {PMC3641583},
  pmid            = {23186606},
  pubmodel        = {Print-Electronic},
  pubstatus       = {ppublish},
  revised         = {2017-02-20},
  timestamp       = {2018.06.20},
}

@Article{guedj10,
  author          = {Guedj, J and Rong, L and Dahari, H and Perelson, A S},
  title           = {A perspective on modelling hepatitis C virus infection.},
  journal         = {Journal of viral hepatitis},
  year            = {2010},
  volume          = {17},
  pages           = {825--833},
  month           = dec,
  issn            = {1365-2893},
  __markedentry   = {[andreas:]},
  abstract        = {By mathematically describing early hepatitis C virus (HCV) RNA decay after initiation of interferon (IFN)-based antiviral therapy, crucial parameters of the in vivo viral kinetics have been estimated, such as the rate of production and clearance of free virus, and the rate of loss of infected cells. Furthermore, by suggesting mechanisms of action for IFN and ribavirin mathematical modelling has provided a means for evaluating and optimizing treatment strategies. Here, we review recent modelling developments for understanding complex viral kinetics patterns, such as triphasic HCV RNA declines and viral rebounds observed in patients treated with pegylated interferon and ribavirin. Moreover, we discuss new modelling approaches developed to interpret the viral kinetics observed in clinical trials with direct-acting antiviral agents, which induce a rapid decline of wild-type virus but also engender a higher risk for emergence of drug-resistant variants. Lastly, as in vitro systems have allowed a better characterization of the virus lifecycle, we discuss new modelling approaches that combine the intracellular and the extracellular viral dynamics.},
  chemicals       = {Antiviral Agents, Interferon-alpha, RNA, Viral, Recombinant Proteins, Polyethylene Glycols, interferon alfa-2b, interferon alfa-2a, Ribavirin, peginterferon alfa-2b, peginterferon alfa-2a},
  citation-subset = {IM},
  completed       = {2011-03-16},
  country         = {England},
  doi             = {10.1111/j.1365-2893.2010.01348.x},
  issn-linking    = {1352-0504},
  issue           = {12},
  keywords        = {Antiviral Agents, pharmacokinetics, pharmacology, therapeutic use; Drug Resistance, Viral; Hepacivirus, drug effects, physiology; Hepatitis C, drug therapy, virology; Humans; Interferon-alpha, pharmacokinetics, pharmacology, therapeutic use; Kinetics; Models, Biological; Polyethylene Glycols, pharmacokinetics, pharmacology, therapeutic use; RNA, Viral, blood; Recombinant Proteins; Ribavirin, pharmacokinetics, pharmacology, therapeutic use},
  mid             = {NIHMS279191},
  nlm-id          = {9435672},
  owner           = {NLM},
  pii             = {JVH1348},
  pmc             = {PMC3070361},
  pmid            = {20723038},
  pubmodel        = {Print-Electronic},
  pubstatus       = {ppublish},
  revised         = {2017-02-20},
  timestamp       = {2018.06.20},
}

@Book{britton03,
  author        = {Britton, Nicholas},
  publisher     = {Springer-Verlag},
  title         = {Essential {Mathematical} {Biology}},
  year          = {2003},
  series        = {Springer {Undergraduate} {Mathematics} {Series}},
  address       = {London},
  __markedentry = {[andreas:6]},
  abstract      = {Essential Mathematical Biology is a self-contained introduction to the fast-growing field of mathematical biology. Written for students with a mathematical background, it sets the subject in its historical context and then guides the reader towards questions of current research interest, providing a comprehensive overview of the field and a solid foundation for interdisciplinary research in the biological sciences. A broad range of topics is covered including: Population dynamics, Infectious diseases, Population genetics and evolution, Dispersal, Molecular and cellular biology, Pattern formation, and Cancer modelling. This book will appeal to 3rd and 4th year undergraduate students studying mathematical biology. A background in calculus and differential equations is assumed, although the main results required are collected in the appendices. A dedicated website at www.springer.co.uk/britton/ accompanies the book and provides further exercises, more detailed solutions to exercises in the book, and links to other useful sites.},
  file          = {Snapshot:C\:\\Users\\andreas\\Zotero\\storage\\W3K9AN5U\\9781852335366.html:text/html},
  isbn          = {978-1-85233-536-6},
  language      = {en},
  owner         = {andreas},
  timestamp     = {2018.06.20},
  url           = {//www.springer.com/us/book/9781852335366},
  urldate       = {2018-06-20},
}

@Misc{otto07,
  author        = {Otto, S. P. and Day, T.},
  title         = {A {Biologist}'s {Guide} to {Mathematical} {Modeling} in {Ecology} and {Evolution}: {Sarah} {Otto}, {Troy} {Day}: 0884639602145: {Amazon}.com: {Books}},
  year          = {2007},
  __markedentry = {[andreas:6]},
  file          = {A Biologist's Guide to Mathematical Modeling in Ecology and Evolution\: Sarah Otto, Troy Day\: 0884639602145\: Amazon.com\: Books:C\:\\Users\\andreas\\Zotero\\storage\\P759XIAG\\0691123446.html:text/html},
  owner         = {andreas},
  timestamp     = {2018.06.20},
  url           = {https://www.amazon.com/Biologists-Mathematical-Modeling-Ecology-Evolution/dp/0691123446},
  urldate       = {2018-06-20},
}

@Book{allman03,
  author        = {Allman, Elizabeth S. and Rhodes, John A.},
  publisher     = {Cambridge University Press},
  title         = {Mathematical {Models} in biology - {An} {Introduction}},
  year          = {2003},
  address       = {New York},
  edition       = {1 edition},
  month         = oct,
  __markedentry = {[andreas:6]},
  abstract      = {Focusing on discrete models across a variety of biological subdisciplines, this introductory textbook includes linear and non-linear models of populations, Markov models of molecular evolution, phylogenetic tree construction from DNA sequence data, genetics, and infectious disease models. Assuming no knowledge of calculus, the development of mathematical topics, such as matrix algebra and basic probability, is motivated by the biological models. Computer research with MATLAB is incorporated throughout in exercises and more extensive projects to provide readers with actual experience with the mathematical models.},
  isbn          = {978-0-521-52586-2},
  language      = {English},
  owner         = {andreas},
  timestamp     = {2018.06.20},
}

@Book{ellner06,
  author        = {Ellner, Stephen and Guckenheimer, John},
  publisher     = {Princeton University Press},
  title         = {Dynamic {Models} in {Biology}},
  year          = {2006},
  address       = {Princeton, N.J},
  edition       = {1 edition},
  month         = apr,
  __markedentry = {[andreas:6]},
  abstract      = {From controlling disease outbreaks to predicting heart attacks, dynamic models are increasingly crucial for understanding biological processes. Many universities are starting undergraduate programs in computational biology to introduce students to this rapidly growing field. In Dynamic Models in Biology, the first text on dynamic models specifically written for undergraduate students in the biological sciences, ecologist Stephen Ellner and mathematician John Guckenheimer teach students how to understand, build, and use dynamic models in biology. Developed from a course taught by Ellner and Guckenheimer at Cornell University, the book is organized around biological applications, with mathematics and computing developed through case studies at the molecular, cellular, and population levels. The authors cover both simple analytic models--the sort usually found in mathematical biology texts--and the complex computational models now used by both biologists and mathematicians. Linked to a Web site with computer-lab materials and exercises, Dynamic Models in Biology is a major new introduction to dynamic models for students in the biological sciences, mathematics, and engineering.},
  isbn          = {978-0-691-12589-3},
  language      = {English},
  owner         = {andreas},
  timestamp     = {2018.06.20},
}

@Article{handel17,
  author          = {Handel, Andreas},
  title           = {Learning infectious disease epidemiology in a modern framework.},
  journal         = {PLoS computational biology},
  year            = {2017},
  volume          = {13},
  pages           = {e1005642},
  month           = oct,
  issn            = {1553-7358},
  __markedentry   = {[andreas:6]},
  citation-subset = {IM},
  completed       = {2017-12-04},
  country         = {United States},
  doi             = {10.1371/journal.pcbi.1005642},
  issn-linking    = {1553-734X},
  issue           = {10},
  keywords        = {Communicable Diseases, epidemiology; Computational Biology; Computer Graphics; Humans; Models, Theoretical; Software; User-Computer Interface},
  nlm-id          = {101238922},
  owner           = {NLM},
  pii             = {PCOMPBIOL-D-17-00604},
  pmc             = {PMC5654261},
  pmid            = {29049284},
  pubmodel        = {Electronic-eCollection},
  pubstatus       = {epublish},
  revised         = {2018-02-01},
  timestamp       = {2018.07.02},
}

@Article{epstein08,
  author    = {Epstein, Joshua M.},
  title     = {Why model?},
  journal   = {Journal of Artificial Societies and Social Simulation},
  year      = {2008},
  volume    = {11},
  number    = {4},
  pages     = {12},
  file      = {Epstein - Why Model.pdf:C\:\\Users\\andreas\\AppData\\Roaming\\Mozilla\\Firefox\\Profiles\\7pcgpjzx.default\\zotero\\storage\\X545ZAC3\\Epstein - Why Model.pdf:application/pdf},
  owner     = {andreas},
  timestamp = {2017.08.08},
  url       = {http://jasss.soc.surrey.ac.uk/11/4/12.html},
  urldate   = {2017-08-08},
}

@Article{luke12,
  author    = {Luke, Douglas A and Stamatakis, Katherine A},
  title     = {Systems science methods in public health: dynamics, networks, and agents},
  journal   = {Annual review of public health},
  year      = {2012},
  volume    = {33},
  pages     = {357--376},
  owner     = {andreas},
  publisher = {Annual Reviews},
  timestamp = {2017.07.07},
}

@Article{basu13,
  author     = {Basu, Sanjay and Andrews, Jason},
  title      = {Complexity in {Mathematical} {Models} of {Public} {Health} {Policies}: {A} {Guide} for {Consumers} of {Models}},
  journal    = {PLoS Medicine},
  year       = {2013},
  volume     = {10},
  number     = {10},
  pages      = {e1001540},
  month      = oct,
  issn       = {1549-1676},
  doi        = {10.1371/journal.pmed.1001540},
  file       = {basu13plosmed - Complexity in Mathematical Models of Public Health Policies - A Guide for Consumers of Models.pdf:C\:\\Users\\andreas\\AppData\\Roaming\\Mozilla\\Firefox\\Profiles\\7pcgpjzx.default\\zotero\\storage\\JNAMJ7XB\\basu13plosmed - Complexity in Mathematical Models of Public Health Policies - A Guide for Consumers of Models.pdf:application/pdf},
  language   = {en},
  owner      = {andreas},
  shorttitle = {Complexity in {Mathematical} {Models} of {Public} {Health} {Policies}},
  timestamp  = {2017.08.08},
  url        = {http://dx.plos.org/10.1371/journal.pmed.1001540},
  urldate    = {2017-08-08},
}

@Article{gunawardena14,
  author     = {Gunawardena, Jeremy},
  title      = {Models in biology:accurate descriptions of our pathetic thinking},
  journal    = {BMC biology},
  year       = {2014},
  volume     = {12},
  number     = {1},
  pages      = {29},
  file       = {gunawardena14bmcbio - Models in biology - accurate descriptions of our pathetic thinking.pdf:C\:\\Users\\andreas\\AppData\\Roaming\\Mozilla\\Firefox\\Profiles\\7pcgpjzx.default\\zotero\\storage\\82J29FFW\\gunawardena14bmcbio - Models in biology - accurate descriptions of our pathetic thinking.pdf:application/pdf},
  owner      = {andreas},
  shorttitle = {Models in biology},
  timestamp  = {2017.08.08},
  url        = {https://bmcbiol.biomedcentral.com/articles/10.1186/1741-7007-12-29},
  urldate    = {2017-08-08},
}

@Article{homer06,
  author     = {Homer, Jack B. and Hirsch, Gary B.},
  title      = {System dynamics modeling for public health: background and opportunities},
  journal    = {American journal of public health},
  year       = {2006},
  volume     = {96},
  number     = {3},
  pages      = {452--458},
  file       = {homer06ajph - system dynamics modeling for public health - background and opportunities.pdf:C\:\\Users\\andreas\\AppData\\Roaming\\Mozilla\\Firefox\\Profiles\\7pcgpjzx.default\\zotero\\storage\\G7KI65U2\\homer06ajph - system dynamics modeling for public health - background and opportunities.pdf:application/pdf},
  owner      = {andreas},
  shorttitle = {System dynamics modeling for public health},
  timestamp  = {2017.08.08},
  url        = {http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2005.062059},
  urldate    = {2017-08-08},
}

@Article{peters14,
  author     = {Peters, David H.},
  title      = {The application of systems thinking in health: why use systems thinking?},
  journal    = {Health Research Policy and Systems},
  year       = {2014},
  volume     = {12},
  number     = {1},
  pages      = {51},
  file       = {peters14hrps - The application of systems thinking in health - why use systems thinking.pdf:C\:\\Users\\andreas\\AppData\\Roaming\\Mozilla\\Firefox\\Profiles\\7pcgpjzx.default\\zotero\\storage\\SPC9IB23\\peters14hrps - The application of systems thinking in health - why use systems thinking.pdf:application/pdf},
  owner      = {andreas},
  shorttitle = {The application of systems thinking in health},
  timestamp  = {2017.08.08},
  url        = {https://health-policy-systems.biomedcentral.com/articles/10.1186/1478-4505-12-51},
  urldate    = {2017-08-08},
}

@Article{may04,
  author        = {May, R.M.},
  title         = {{Uses and abuses of mathematics in biology}},
  journal       = {Science},
  year          = {2004},
  volume        = {303},
  pages         = {790--793},
  date-modified = {2008-03-06 11:53:41 -0500},
  owner         = {andreas},
  timestamp     = {2018.09.19},
}

@Article{chubb10,
  author    = {Chubb, Mikayla C. and Jacobsen, Kathryn H.},
  title     = {Mathematical modeling and the epidemiological research process},
  journal   = {European Journal of Epidemiology},
  year      = {2010},
  volume    = {25},
  number    = {1},
  pages     = {13--19},
  month     = jan,
  issn      = {0393-2990, 1573-7284},
  doi       = {10.1007/s10654-009-9397-9},
  file      = {chubb10eurjepi - jacobson - Mathematical modeling and the epidemiological research process.pdf:C\:\\Users\\andreas\\AppData\\Roaming\\Mozilla\\Firefox\\Profiles\\7pcgpjzx.default\\zotero\\storage\\KQGGKK7E\\chubb10eurjepi - jacobson - Mathematical modeling and the epidemiological research process.pdf:application/pdf},
  language  = {en},
  owner     = {andreas},
  timestamp = {2017.08.08},
  url       = {http://link.springer.com/10.1007/s10654-009-9397-9},
  urldate   = {2017-08-08},
}

@Article{garnett11,
  author    = {Garnett, Geoffrey P. and Cousens, Simon and Hallett, Timothy B. and Steketee, Richard and Walker, Neff},
  title     = {Mathematical models in the evaluation of health programmes},
  journal   = {The Lancet},
  year      = {2011},
  volume    = {378},
  number    = {9790},
  pages     = {515--525},
  file      = {garnett11lancet - Mathematical models in the evaluation of health programmes.pdf:C\:\\Users\\andreas\\AppData\\Roaming\\Mozilla\\Firefox\\Profiles\\7pcgpjzx.default\\zotero\\storage\\M6EMJCKA\\garnett11lancet - Mathematical models in the evaluation of health programmes.pdf:application/pdf},
  owner     = {andreas},
  timestamp = {2017.08.08},
  url       = {http://www.sciencedirect.com/science/article/pii/S014067361061505X},
  urldate   = {2017-08-08},
}

@Article{sterman06,
  author    = {Sterman, John D.},
  title     = {Learning from evidence in a complex world},
  journal   = {American journal of public health},
  year      = {2006},
  volume    = {96},
  number    = {3},
  pages     = {505--514},
  file      = {sterman06ajph - learning from evidence in a complex world.pdf:C\:\\Users\\andreas\\AppData\\Roaming\\Mozilla\\Firefox\\Profiles\\7pcgpjzx.default\\zotero\\storage\\JJPTPVDN\\sterman06ajph - learning from evidence in a complex world.pdf:application/pdf},
  owner     = {andreas},
  timestamp = {2017.08.08},
  url       = {http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2005.066043},
  urldate   = {2017-08-08},
}

@Comment{jabref-meta: databaseType:bibtex;}
